This study seeks to explore the combined effects of the STING agonist c‐di‐AMP and the herbal compound ginsenoside RG3 in reversing cisplatin resistance in gastric cancer SGC‐7901/DDP cells. The gene discussed is STING1; the disease is gastric cancer.